Motilal Oswal Pharma Fund - Regular Plan - Growth

Motilal Oswal Pharma Fund - Regular Plan - Growth overview and fund details

Motilal Oswal Pharma Fund - Regular Plan - Growth ek equity mutual fund hai jo ki pharma sector mein invest karta hai. Iska objective hai long-term capital appreciation. Ye fund un investors ke liye suitable hai jo higher risk tolerance rakhte hain aur pharma sector ki growth potential ko samajhte hain. Fund ka investment style growth-oriented hai aur ismein large-cap aur mid-cap pharma stocks ko include kiya gaya hai. Investors ke liye ye ek acha option ho sakta hai agar unhe healthcare aur pharmaceuticals mein interest hai.

Motilal Oswal Pharma Fund - Regular Plan - Growth yearly return performance

Motilal Oswal Pharma Fund - Regular Plan - Growth ke returns ka comparison dekhen toh isne 1 saal mein 5.06% return diya hai, jo ki thoda moderate hai. 3 saal ki performance ki baat karein toh 10.49% return milta hai, jo accha hai aur isse long-term investors ko kuch stability milti hai. 5 saal ka return 8.27% hai, jo is fund ko ek consistent performer banata hai. Fund ka benchmark Nifty Pharma TRI hai, aur iski performance benchmark ke comparison mein kaafi achi rahi hai. Yeh fund market volatility se bhi kuch extent tak bachne mein successful raha hai, khas karke jab pharma sector mein growth trends dekhe gaye hain. Fund manager Niket Shah ki guidance ne iske returns ko enhance karne mein madad ki hai. Kya aapko lagta hai ki ye returns aane wale samay mein improve honge? Chaliye dekhte hain.

Motilal Oswal Pharma Fund - Regular Plan - Growth ke top holdings aur portfolio

Is fund ke top holdings mein kuch major pharma companies shamil hain. Sun Pharmaceutical Industries Ltd. 20.5% ka share rakhta hai, jabki Dr. Reddy's Laboratories Ltd. 12.8% par hai. Cipla Ltd. ka allocation 10.4%, Divi's Laboratories Ltd. ka 9.8%, aur Torrent Pharmaceuticals Ltd. ka 7.2% hai. Is fund ka sector allocation bhi kaafi interesting hai. Pharma stocks ke alawa, yeh healthcare aur biotechnology mein bhi invest karta hai, jo ki growth potential ko enhance karta hai. Portfolio diversification se investors ko kuch stability milti hai, khas karke jab market volatile hota hai. Yeh fund un logon ke liye accha hai jo pharma sector ki growth se fayda uthana chahte hain.

Motilal Oswal Pharma Fund - Regular Plan - Growth risk analysis and volatility

Motilal Oswal Pharma Fund - Regular Plan - Growth ka riskometer "Very High" hai, jo ki is fund ke volatility ko darshata hai. Ismein jabardast price fluctuations ho sakte hain, khas karke jab market conditions unfavorable hoti hain. Is fund ka expense ratio 1.95% hai, jo ki industry standards se thoda upar hai. Lekin, agar aap risk ko le sakte hain aur long-term wealth creation mein interested hain, to yeh fund aapke liye sahi ho sakta hai. Yeh fund un investors ke liye suitable hai jo higher risk profile rakhte hain aur market ke ups and downs ko sambhal sakte hain.

Motilal Oswal Pharma Fund - Regular Plan - Growth advantages and disadvantages

• Pros:
  • Strong historical performance in pharma sector.
  • Diversified portfolio with top holdings in major companies.
  • Experienced fund manager with 3.5 years tenure.
  • Long-term capital appreciation potential.
• Cons:
  • Very high risk profile may not be suitable for all investors.
  • Higher expense ratio compared to some peers.
  • Market volatility can impact short-term returns.